scPharmaceuticals Inc
NASDAQ:SCPH

Watchlist Manager
scPharmaceuticals Inc Logo
scPharmaceuticals Inc
NASDAQ:SCPH
Watchlist
Price: 5.67 USD Market Closed
Market Cap: 304.4m USD

Relative Value

The Relative Value of one SCPH stock under the Base Case scenario is hidden USD. Compared to the current market price of 5.67 USD, scPharmaceuticals Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SCPH Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
31
vs Industry
25
Median 3Y
6.5
Median 5Y
4.4
Industry
2.6
Forward
4.1
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-4.3
Industry
21.4
Forward
-5.1
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-5
Industry
16.4
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-4.2
Industry
22.8
vs History
vs Industry
14
Median 3Y
4.7
Median 5Y
3.3
Industry
2.2
vs History
28
vs Industry
31
Median 3Y
6.3
Median 5Y
3.9
Industry
2.9
Forward
4.2
vs History
28
vs Industry
37
Median 3Y
9.1
Median 5Y
5.7
Industry
5.5
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-3.1
Industry
13
Forward
-5.8
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-3.1
Industry
16.5
Forward
-5.7
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-3.1
Industry
15.6
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-3.1
Industry
18.7
vs History
65
vs Industry
19
Median 3Y
8.8
Median 5Y
21.6
Industry
1.9

Multiples Across Competitors

SCPH Competitors Multiples
scPharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
scPharmaceuticals Inc
NASDAQ:SCPH
302.2m USD 6 -3.3 -3.9 -3.9
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 5.4 19.9 16.2 21.1
CH
Roche Holding AG
SIX:ROG
258.9B CHF 4.2 27.4 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
208.7B GBP 4.8 29.9 108.3 158.5
US
Merck & Co Inc
NYSE:MRK
264.8B USD 4.1 13.9 9.9 11.7
CH
Novartis AG
SIX:NOVN
207.7B CHF 4.7 18.2 11.6 14.9
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.7 14.4 10 11.7
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
US
scPharmaceuticals Inc
NASDAQ:SCPH
Average P/E: 24.2
Negative Multiple: -3.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.4
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.9
37%
0.8
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
CH
Novartis AG
SIX:NOVN
18.2
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
14.4
3%
4.8
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
scPharmaceuticals Inc
NASDAQ:SCPH
Average EV/EBITDA: 439.7
Negative Multiple: -3.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
5%
2.3
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
CH
Novartis AG
SIX:NOVN
11.6
6%
1.9
DK
Novo Nordisk A/S
CSE:NOVO B
10
1%
10
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
scPharmaceuticals Inc
NASDAQ:SCPH
Average EV/EBIT: 1 883.3
Negative Multiple: -3.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.5
23%
6.9
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
CH
Novartis AG
SIX:NOVN
14.9
12%
1.2
DK
Novo Nordisk A/S
CSE:NOVO B
11.7
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5